2006
DOI: 10.1016/j.lfs.2005.10.020
|View full text |Cite
|
Sign up to set email alerts
|

Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

17
52
1
4

Year Published

2007
2007
2020
2020

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 96 publications
(74 citation statements)
references
References 39 publications
17
52
1
4
Order By: Relevance
“…In line with the above study, in our animal model, invasive blood pressure measurement showed an increase in MAP and Ang II-induced ⌬MAP, which could not be reversed upon diet reversal. Metformin has been reported to have an anti-hypertensive effect in diabetes (31). Our study also found that metformin significantly mitigated the basal as well as the Ang IIinduced MAP elevation.…”
Section: Discussionsupporting
confidence: 80%
“…In line with the above study, in our animal model, invasive blood pressure measurement showed an increase in MAP and Ang II-induced ⌬MAP, which could not be reversed upon diet reversal. Metformin has been reported to have an anti-hypertensive effect in diabetes (31). Our study also found that metformin significantly mitigated the basal as well as the Ang IIinduced MAP elevation.…”
Section: Discussionsupporting
confidence: 80%
“…[32][33][34] Summarizing, these results allow us to suggest that n-STZ diabetes leads to an increase in superoxide levels, which could contribute to an impaired NO vasodilator-dependent responses found previously. 19) Corroborating with our in vivo data, Majithiya et al (2006) 35) showed an increase in superoxide concentration in aorta of adult STZ-induced diabetic rats.…”
Section: Discussionsupporting
confidence: 67%
“…Recently, Majithiya and Balaraman [34] reported that metformin protects liver, kidney and aorta tissues against lipid peroxidation promoted by streptozotocin-induced diabetes. It has also been shown that metformin decreases the level of lipid peroxidation markers in low-density and high-density lipoprotein particles obtained from adult type 2 diabetic patients [35].…”
Section: Discussionmentioning
confidence: 99%